0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Environmental Sources Gut & Microbiome Human Health Effects Nanoplastics Remediation Sign in to save

Determination of the ability of native potential probiotic lactobacillus strains in nanoplastic bioremoval in an in-vitro Model

Ecotoxicology and Environmental Safety 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count.
Nayereh Rezaie Rahimi, Mohammad Hoseini, Hasan Hashemi, Abooalfazl Azhdarpoor, Hamid Gholami Pourbadie, Mehdi Dehghani, Mahdi Rohani

Summary

Researchers tested 88 native probiotic Lactobacillus strains for their ability to bind and remove polystyrene nanoplastics in laboratory conditions, finding that a cocktail of three strains achieved up to 77% removal. The most effective strain, L. plantarum RP13, showed strong nanoplastic adhesion confirmed by microscopy imaging. The study suggests that certain probiotic bacteria may have potential as a biological approach to reducing nanoplastic exposure in the gastrointestinal tract.

Polymers
Body Systems
Study Type In vivo

Nanoplastics (NPs) are emerging environmental pollutants that pose significant health risks, particularly due to their accumulation in the gastrointestinal tract. This study evaluates the ability of 88 native probiotic Lactobacillus strains to remove polystyrene nanoplastics (PS-NPs) in an in-vitro model. Three resistant strains L. plantarum RP13, RP134, and RP225-were selected based on disk diffusion screening. A cocktail of these strains demonstrated high percentages of NP binding: 77 % ± 2.5 at 0.1 mg/mL, 76 %± 2.1 at 0.2 mg/mL, and 67 %± 3.0 at 0.4 mg/mL. Among individual strains, RP13 exhibited the highest removal capacity. Fluorescence and electron microscopy confirmed PS-NP adhesion to bacterial surfaces. Zeta potential measurements showed a shift from -30.32 mV to -21.87 mV after bacterial exposure, indicating surface interaction. Cytotoxicity assays on HT-29 cells revealed dose-dependent toxicity of PS-NPs, which was significantly reduced by treatment with the Lactobacillus cocktail most notably at concentrations between 62.5 and 15.62 µg/mL. These promising in-vitro results suggest that our native probiotic Lactobacillus strains may offer a sustainable strategy for mitigating nanoplastic toxicity in the gastrointestinal tract; however, validation through in-vivo studies is essential to confirm their therapeutic potential and translational relevance.

Share this paper